TWI873221B - 口腔內崩散錠 - Google Patents

口腔內崩散錠 Download PDF

Info

Publication number
TWI873221B
TWI873221B TW109139356A TW109139356A TWI873221B TW I873221 B TWI873221 B TW I873221B TW 109139356 A TW109139356 A TW 109139356A TW 109139356 A TW109139356 A TW 109139356A TW I873221 B TWI873221 B TW I873221B
Authority
TW
Taiwan
Prior art keywords
disorder
orally disintegrating
starch
lubricant
disintegrating tablet
Prior art date
Application number
TW109139356A
Other languages
English (en)
Chinese (zh)
Other versions
TW202128167A (zh
Inventor
劒持卓
山﨑浩之
岡慶一
古関美香
Original Assignee
日商大塚製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商大塚製藥股份有限公司 filed Critical 日商大塚製藥股份有限公司
Publication of TW202128167A publication Critical patent/TW202128167A/zh
Application granted granted Critical
Publication of TWI873221B publication Critical patent/TWI873221B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW109139356A 2019-11-11 2020-11-11 口腔內崩散錠 TWI873221B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
WOPCT/JP2019/044118 2019-11-11
PCT/JP2019/044118 WO2021095092A1 (ja) 2019-11-11 2019-11-11 口腔内崩壊錠

Publications (2)

Publication Number Publication Date
TW202128167A TW202128167A (zh) 2021-08-01
TWI873221B true TWI873221B (zh) 2025-02-21

Family

ID=75911893

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109139356A TWI873221B (zh) 2019-11-11 2020-11-11 口腔內崩散錠

Country Status (9)

Country Link
US (1) US20220387423A1 (https=)
EP (1) EP4059502A4 (https=)
JP (3) JP7395607B2 (https=)
CN (1) CN114650821A (https=)
AU (1) AU2020384456B2 (https=)
CA (1) CA3161119A1 (https=)
PH (1) PH12022551117A1 (https=)
TW (1) TWI873221B (https=)
WO (2) WO2021095092A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠
EP4574134A1 (en) * 2023-12-22 2025-06-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet comprising brexpiprazole

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112861A (ja) * 2001-03-06 2005-04-28 Kyowa Hakko Kogyo Co Ltd 口腔内速崩壊錠
JP2010053043A (ja) * 2008-08-26 2010-03-11 Takada Seiyaku Kk 口腔内速崩壊錠
JP2010270040A (ja) * 2009-05-20 2010-12-02 Kyoto Pharmaceutical Industries Ltd 口腔内崩壊錠
TW201347792A (zh) * 2012-04-24 2013-12-01 Daiichi Sankyo Co Ltd 口腔內崩壞錠及其製造方法
CN106994119A (zh) * 2016-01-22 2017-08-01 浙江华海药业股份有限公司 含有依匹哌唑或其盐的口腔崩解片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010001106A1 (en) * 1996-04-16 2001-05-10 Tomohiro Yoshinari D-mannitol and its preparation
US8153161B2 (en) * 2003-12-09 2012-04-10 Dainippon Sumitomo Pharma Co., Ltd. Medicament-containing particle and a solid preparation containing the particle
JP3996626B2 (ja) * 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
JP5004236B2 (ja) * 2005-02-09 2012-08-22 キッセイ薬品工業株式会社 口腔内崩壊錠
BRPI0808889A2 (pt) * 2007-03-13 2014-11-11 Dainippon Sumitomo Pharma Co Comprimido desintegrante oral
US8431618B2 (en) * 2008-03-31 2013-04-30 Asahi Kasei Chemicals Corporation Processed starch powder with excellent disintegration properties and manufacturing method thereof
CN102119034B (zh) * 2008-06-13 2013-05-22 大日本住友制药株式会社 在口腔中快速崩解的片剂和制备其的方法
WO2010021300A1 (ja) * 2008-08-18 2010-02-25 三菱商事フードテック株式会社 新規マンニトール打錠用賦形剤
JP5733930B2 (ja) * 2009-09-09 2015-06-10 武田薬品工業株式会社 固形製剤
JO3753B1 (ar) * 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
JP5897196B1 (ja) * 2015-10-05 2016-03-30 大同化成工業株式会社 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
CN105412036A (zh) * 2015-12-24 2016-03-23 北京康立生医药技术开发有限公司 依匹哌唑口腔崩解片
JP6201017B2 (ja) * 2016-08-04 2017-09-20 佐藤製薬株式会社 硬度及び崩壊性に優れた口腔内崩壊錠の製造方法及び該製造方法により製造される口腔内崩壊錠
WO2021095092A1 (ja) 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005112861A (ja) * 2001-03-06 2005-04-28 Kyowa Hakko Kogyo Co Ltd 口腔内速崩壊錠
JP2010053043A (ja) * 2008-08-26 2010-03-11 Takada Seiyaku Kk 口腔内速崩壊錠
JP2010270040A (ja) * 2009-05-20 2010-12-02 Kyoto Pharmaceutical Industries Ltd 口腔内崩壊錠
TW201347792A (zh) * 2012-04-24 2013-12-01 Daiichi Sankyo Co Ltd 口腔內崩壞錠及其製造方法
CN106994119A (zh) * 2016-01-22 2017-08-01 浙江华海药业股份有限公司 含有依匹哌唑或其盐的口腔崩解片及其制备方法

Also Published As

Publication number Publication date
WO2021095779A1 (ja) 2021-05-20
CN114650821A (zh) 2022-06-21
TW202128167A (zh) 2021-08-01
EP4059502A4 (en) 2023-12-13
PH12022551117A1 (en) 2023-08-23
CA3161119A1 (en) 2021-05-20
JP7395607B2 (ja) 2023-12-11
JP2024026205A (ja) 2024-02-28
WO2021095092A1 (ja) 2021-05-20
AU2020384456B2 (en) 2026-03-12
AU2020384456A1 (en) 2022-06-09
JP7676510B2 (ja) 2025-05-14
EP4059502A1 (en) 2022-09-21
JP2025118718A (ja) 2025-08-13
US20220387423A1 (en) 2022-12-08
JPWO2021095779A1 (https=) 2021-05-20

Similar Documents

Publication Publication Date Title
TWI634908B (zh) 包含有７－［４－（４－苯并［ｂ］噻吩－４－基－哌－１－基）丁氧基］－１Ｈ－喹啉－２－酮或其鹽之錠劑
TWI254640B (en) Use of a polymer of acrylic type as a disintegration agent
JP5537943B2 (ja) 速崩壊性固形製剤
JP2025118718A (ja) 口腔内崩壊錠
CN110475544B (zh) 包含氨基甲酸酯化合物的口腔崩解片
TW201036649A (en) Tablets and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
WO2022218357A1 (zh) 一种布瑞哌唑口溶膜包合物、其制备方法及应用
CN103520128B (zh) 一种普拉克索的缓释片剂、制备方法及其用途
TW202245769A (zh) 布瑞哌唑口溶膜組合物、其製備方法及用途
KR101531030B1 (ko) 미르타자핀 함유 구강붕해정
TW201936175A (zh) 粒狀組合物、粒狀組合物之製造方法、及粒狀組合物之溶出性改善方法
CN115192549A (zh) 一种布瑞哌唑物口腔薄膜剂、其制备方法及应用
WO2018159673A1 (ja) エリスリトール顆粒およびその製造方法、ならびにそれを用いた錠剤の製造方法および錠剤
CN110167552A (zh) 医药组合物及其制造方法
JP2021104973A (ja) 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠
JPWO2017047586A1 (ja) 錠剤
WO2019230937A1 (ja) 溶出性に優れた経口固形製剤
CN105555316B (zh) 通过二阶段的湿式制粒工序制备的崩解性颗粒组合物及含有该组合物的口腔内崩解片剂
EA051121B1 (ru) Перорально распадающаяся таблетка
HK40071352A (en) Orally disintegrating tablet
HK40066890A (zh) 口腔崩解片剂
TW201113051A (en) Oral disintegrating tablet and manufacturing method thereof
CN109674759A (zh) 一种达泊西汀药物组合物及其制备方法
CN115634208B (zh) 一种帕罗西汀缓释片及其制备方法
CN121265568A (zh) 一种用于治疗失眠的黏膜给药膜剂